Boothbay Fund Management, LLC Mei Pharma, Inc. Transaction History

Boothbay Fund Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $183,972 - $266,088	-78,958 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $9,727 - $11,541	-3,860 Reduced 4.66%	78,958 $218,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $95,817 - $134,513	36,853 Added 80.18%	82,818 $236,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $36,005 - $59,350	13,189 Added 40.24%	45,965 $158,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $40,921 - $52,253	15,739 Added 92.38%	32,776 $87,000
Q3 2020 Nov 16, 2020	BUY	$2.46 - $4.27 $41,911 - $72,747	17,037 New	17,037 $53,000
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $27,115 - $80,410	-18,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $6,525 - $22,185	8,700 Added 87.0%	18,700 $30,000
Q4 2019 Feb 14, 2020	BUY	$1.65 - $2.48 $16,500 - $24,800	10,000 New	10,000 $25,000
Q2 2019 Aug 14, 2019	SELL	$2.45 - $3.32 $94,734 - $128,374	-38,667 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $85,496 - $109,923	-33,927 Reduced 46.74%	38,667 $119,000
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $111,100 - $237,246	57,865 Added 392.86%	72,594 $192,000
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $49,931 - $67,900	14,729 New	14,729 $63,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.